本综述深度解析血红蛋白变异体Hb Tacoma对糖化血红蛋白(HbA1c)检测的干扰机制，系统评估Bio-Rad Variant II、D-100、Sebia Cap3等6种 ...

COPD patients are at an increased risk of developing lung infections such as pneumonia and bronchitis. Credit: mi_viri/Shutterstock. Upstream Bio has dosed the first subject in the randomised Phase II ...

PHILADELPHIA, May 14, 2025--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research published today in Science ...

PROTEAN II xi系统组件包括电泳槽、中央制冷芯、托架、灌胶架等，适用于多种电泳分离，如SDS-PAGE、双向电泳、核酸电泳等。该系统支持16 cm和20 cm两种长度的凝胶，并可通过IPG转换组合套件扩展至适合17和18 cm IPG胶条的第二向电泳。其独特的单螺纹夹和中央制冷芯 ...

BIO-RAD伯乐PROTEAN II xi和XL多板电泳槽适用于中通量的双向电泳实验，支持同时进行6块凝胶电泳。配备高效的冷却系统和专用配件，能够提供稳定且优化的双向分离效果，尤其适合需要高功率电泳的应用。该设备通过灵活的组件配置，满足不同实验需求，并支持 ...

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for ...

Aug 1 (Reuters) - Bio-Rad Laboratories (BIO.N), opens new tab cut its annual revenue growth forecast on Thursday, dragged down by weak demand for clinical diagnostics products from biotech clients.

HAMBURG, Germany - Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Variant Bio, Inc. have entered into a strategic collaboration aimed at discovering and ...

COLLABORATION LEVERAGES VARIANT BIO'S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC'S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC ...

The Phase II clinical trial will analyse verekitug for chronic rhinosinusitis with nasal polyps. Credit: Elena M. Tarasova / Shutterstock. Upstream Bio has initiated the dosing of the first subjects ...